This approval is another example of the benefits of the Orphan Drug program, which provides incentives for the development of treatments for diseases affecting fewer than 200,000 patients in the United States a year. Until now, Pompe disease has had no approved treatment.
-Dr. Galson
Select a background
More quotes by Dr. Galson
Popular Authors
A curated listing of popular authors.